首页> 外国专利> Mutation of antibiotic-producing strains of streptomyces

Mutation of antibiotic-producing strains of streptomyces

机译:产链霉菌的抗生素菌株的突变

摘要

Mutants having enhanced antibiotic-producing capacity are obtained by subjecting an antibiotic-producing strain of a species of the genus Streptomyces to the mutagenic action of a compound selected from 1-(5-nitrofurfurylidene amino)-2-imidazolino thione, 5-nitro-2-furaldehyde semi carbazone, N-(5-nitro-2-furfurylidene)-1-amino-hydantoin and 5-nitro-2-furaldehyde, and selecting in a conventional manner from the various colonies produced a strain of improved antibiotic activity. Mutation is effected in a nutrient medium containing from 1.0 to 20.0 g /ml of the said compound and also 0.01 to 0.5% by volume of an acid amide e.g. dimethylformamide. The species may be Streptomyces aureofaciens, S. rimosus, S. antibioticus, S. erythreus, S. fradiae, S. griseus, S. niveus, S. noursei and S. hydroscopicus.ALSO:Mutants having enhanced antibiotic-producing capacity are obtained by subjecting an antibiotic-producing strain of a species of the genus Streptomyces to the mutagenic action of a compound selected from 1-(5-nitrofurfurylidene amino) - 2 - imidazolino thione, 5 - nitro-2 - furaldehyde semicarbazone, N - (5 - nitro-2 - furfurylidene) - 1 - amino - hydantoin and 5 - nitro - 2 - furaldehyde, and selecting in a conventional manner from the various colonies produced a strain of improved antibiotic activity. Mutation is effected in a nutrient medium containing from 1.0-20.0 g /ml. of the said compound and also 0.01 to 0.5% by volume of an acid amide such as dimethylformamide. The species may be Streptomyces aureofaciens, S. rimosus, S. antibioticus, S. erythreus, S. fradiae, S. griseus, S. niveus, S. noursei and S. hydroscopicus. Examples relate to the preparation of Streptomyces aureofaciens A-802.934 (deposited at the State Hygienic Institute Budapest, Hungary under No. 640.304.26) and to the cultivation of this mutant for the preparation of tetracycline in a medium containing chloride ions.
机译:通过使链霉菌(Streptomyces)属的一种抗生素生产菌株经受选自1-(5-硝基糠基亚氨基氨基)-2-咪唑啉基硫酮,5-硝基-噻吩基的化合物的诱变作用,可以获得具有增强的抗生素生产能力的突变体。 2-呋喃半碳氮酮,N-(5-硝基-2-呋喃基)-1-氨基-乙内酰脲和5-硝基-2-呋喃醛,并以常规方式从各个菌落中选择,从而产生了一种具有改善的抗生素活性的菌株。在营养培养基中进行突变,所述营养培养基包含1.0至20.0g / ml的所述化合物以及0.01至0.5体积%的酰胺,例如1.0-0.5体积%。二甲基甲酰胺。该物种可以是金黄色链霉菌,里莫斯链霉菌,抗生素链球菌,赤藓链球菌,弗拉迪氏菌,灰霉菌,尼维斯链霉菌,诺氏链球菌和吸水链球菌。通过使链霉菌属的一种产生抗生素的菌株经受选自1-(5-硝基糠基亚氨基)-2-咪唑啉基硫酮,5-硝基-2-呋喃半脲,N-(5的化合物)的诱变作用-硝基-2-糠基亚基)-1-氨基-乙内酰脲和5-硝基-2-糠醛,并以常规方式从各个菌落中选择产生了提高了抗生素活性的菌株。在含有1.0-20.0g / ml的营养培养基中进行突变。所述化合物的50%和0.01-0.5体积%的酰胺如二甲基甲酰胺。该物种可以是金黄色链霉菌,链球菌,抗生素链球菌,赤藓菌,弗拉迪氏菌,灰霉菌,细叶链霉菌,诺氏链球菌和吸水链球菌。实例涉及金黄色链霉菌A-802.934的制备(保藏在匈牙利布达佩斯国家卫生研究所,编号640.304.26),以及涉及该突变体的培养,以在含氯离子的培养基中制备四环素。

著录项

  • 公开/公告号NL6506218A

    专利类型

  • 公开/公告日1965-11-15

    原文格式PDF

  • 申请/专利权人

    申请/专利号NL19650006218

  • 发明设计人

    申请日1965-05-14

  • 分类号C12N15/01;C12P1/06;

  • 国家 NL

  • 入库时间 2022-08-23 15:20:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号